Abiomed (pronounced “AB’-EE-O-MED”), maker of ventricular assist devices, has recently received US FDA approval for their integrated cannula tubing system. Cardiovascular surgeons, this one’s for you…
Abiomed’s new cannula system provides an enhanced benefit since patients will not require a second sternotomy during off-pump explantations. Off-pump (also called beating heart) techniques provide potential patient benefits of a shorter hospital stay and recovery time, less bleeding, less potential for infection, and less trauma. The new cannula system consists of a 42 French cannula, surgical sewing cuff and an inline connector for precise implantation and reduced blood loss for patients in acute heart failure.
“This new cannula system offers cardiovascular surgeons a standardized and efficient circulatory support procedure for use with patients in acute heart failure,” said Daniel Raess, M.D., F.A.C.C., F.A.C.S., Medical Advisor at Abiomed. “The device makes for easier off-pump implantations, minimizes damage to the heart muscle and blood, and allows for easier explant of circulatory support once the native function of the patient’s heart has returned.”
More from Abiomed